Last update 10 Jan 2026

NWRD06

Overview

Basic Info

Drug Type
DNA vaccine, Therapeutic vaccine
Synonyms
NWRD06
Target
GPC3
Action
inhibitors
Mechanism
GPC3 inhibitors(Glypican-3 inhibitors)
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
GPC3 Positive Hepatocellular CarcinomaHepatitis B Virus-Related Hepatocellular Carcinoma
Inactive Indication-
Originator Organization
Newish Technology (Beijing) Co., Ltd.Newish Technology (Beijing) Co., Ltd.
Active Organization
Newish Technology (Beijing) Co., Ltd.Newish Technology (Beijing) Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with NWRD06
CTR20254905
/ RecruitingPhase 2
评价NWRD06在肝细胞癌根治术后患者中有效性和安全性的II期临床研究
[Translation] A Phase II clinical study evaluating the efficacy and safety of NWRD06 in patients after radical resection of hepatocellular carcinoma.
NCT07324304
/ RecruitingPhase 2
A Phase II Clinical Study to Evaluate the Efficacy and Safety of NWRD06 in Patients With Hepatocellular Carcinoma After Curative Resection.
NCT06088459
/ Unknown statusPhase 1
Phase I Safety and Immunogenicity Study of NWRD06 in Hepatocellular Carcinoma Patients After Radical Resection
100 Clinical Results associated with NWRD06
Login to view more data
100 Translational Medicine associated with NWRD06
Login to view more data
100 Patents (Medical) associated with NWRD06
Login to view more data
100 Deals associated with NWRD06
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
GPC3 Positive Hepatocellular CarcinomaPhase 2
China
Newish Technology (Beijing) Co., Ltd.Newish Technology (Beijing) Co., Ltd.
12 Dec 2025
Hepatitis B Virus-Related Hepatocellular CarcinomaPhase 2
China
Newish Technology (Beijing) Co., Ltd.Newish Technology (Beijing) Co., Ltd.
08 Dec 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free